Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
Autor: | Scott Lovell, Vishnu C. Damalanka, Kyeong-Ok Chang, William C. Groutas, Anthony R. Fehr, A.D. Rathnayake, Stanley Perlman, N. Mehzabeen, Gerald H. Lushington, Yunjeong Kim, Anushka C. Galasiti Kankanamalage, Kevin P. Battaile |
---|---|
Rok vydání: | 2018 |
Předmět: |
Models
Molecular 0301 basic medicine Middle East respiratory syndrome coronavirus viruses medicine.medical_treatment 030106 microbiology Cysteine Proteinase Inhibitors Crystallography X-Ray medicine.disease_cause Antiviral Agents Article Structure-Activity Relationship Viral Proteins 03 medical and health sciences chemistry.chemical_compound Piperidines Chlorocebus aethiops Drug Discovery medicine Animals Moiety Vero Cells Cells Cultured Pharmacology Protease Cell Death Dose-Response Relationship Drug Molecular Structure Chemistry Organic Chemistry 3C Viral Proteases Biological activity General Medicine Combinatorial chemistry Small molecule 3. Good health Cysteine Endopeptidases 030104 developmental biology Mechanism of action Viral replication Drug Design Cats Middle East Respiratory Syndrome Coronavirus Piperidine medicine.symptom |
Zdroj: | European Journal of Medicinal Chemistry |
ISSN: | 0223-5234 |
DOI: | 10.1016/j.ejmech.2018.03.004 |
Popis: | There are currently no approved vaccines or small molecule therapeutics available for the prophylaxis or treatment of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infections. MERS-CoV 3CL protease is essential for viral replication; consequently, it is an attractive target that provides a potentially effective means of developing small molecule therapeutics for combatting MERS-CoV. We describe herein the structure-guided design and evaluation of a novel class of inhibitors of MERS-CoV 3CL protease that embody a piperidine moiety as a design element that is well-suited to exploiting favorable subsite binding interactions to attain optimal pharmacological activity and PK properties. The mechanism of action of the compounds and the structural determinants associated with binding were illuminated using X-ray crystallography. |
Databáze: | OpenAIRE |
Externí odkaz: |